# Minglie Hu

> Minglie Hu is a Series C investor at Lighthouse Capital Management backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lighthouse Capital Management](https://shizune.co/investors/profile/lighthouse-capital-management)
- Total investments: 2
- Last investment: Jan 2016
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/minglie-hu-bb011910/

Minglie Hu is a Series C investor at Lighthouse Capital Management focused on Medical and Health Care. Minglie Hu is the Founder and currently works as the CEO for ZHANG YUE YOU XI.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| iHear Medical | iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearingaid.iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR.iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers.iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies. | $2.6M | Series C | Jan 15, 2016 |  |
| iHear Medical | iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearingaid.iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR.iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers.iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies. | $5M | Series C | Nov 24, 2014 |  |

2 of 2 investments shown.

## Co-investors
- [Aphelion Capital](https://shizune.co/investors/profile/aphelion-capital) — VC Fund, 2 deals together

## About Lighthouse Capital Management

VC Fund · Shanghai, China

Lighthouse Capital Management is an early venture capital fund focusing on the Chinese and US markets. It has been focusing on angel/VC equity investment in excellent content and products and currently manages two RMB Fund and a dollar fund.The firm has invested in more than 40 growth projects in mainland China and overseas, focusing onhardware equipment and "Internet +" method empowerment and enterprise data services. It is managing billions of dollars in total assets, investing in the total market value of domestic and foreign companies over 100 Billion dollars.Lighthouse Capital was founded in 2011 and is based in Shanghai, China.

4 contacts available at Lighthouse Capital Management.

| Name | Title | Profile |
| --- | --- | --- |
| Danny Qin | Partner | https://shizune.co/investors/profile/danny-qin |
| Minglie Hu | Founding Partner, Chairman | https://shizune.co/investors/profile/minglie-hu |
| Qianqian Yang | Partner | https://shizune.co/investors/profile/qianqian-yang |
| Wei Li | Founding Partner, President | https://shizune.co/investors/profile/wei-li-f8bb |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Minglie Hu invest in?

Minglie Hu invests primarily in Medical, Health Care and Medical Device startups, most often at Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Minglie Hu last invest?

The most recent investment recorded for Minglie Hu closed in Jan 2016. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co